Conference outline, Warsaw, September 22-24, 2010

Important! We would like to inform the participants that the entire conference and panel discussions will be conducted in English with no translation into other languages.

 

You can download Conference Programme here.

 

September 22

2.00 pm – 7.00 pm

Early registration

 

6.00 pm

Evening reception and banquet

 

7.00 pm

Keynote lecture
Robert Porter Lynch, CEO, The Warren Group
Trust as the foundation for collaborative innovation in biomedicine

 

September 23

9.00 am - 10.45 am

Opening plenary session
Chairman: Prof. Sławomir Majewski, Vice rector of the Medical University of Warsaw

• Welcome by the Rector of the Medical University of Warsaw

Prof. Marek Krawczyk

• Introductory remarks from the Ministry of Science and Higher Education

Prof. Jerzy Szwed, Deputy State Secretary, Ministry of Science and Higher Education

• The role of EU funds in inducing innovation

Ms Charlina Vitcheva, director for Denmark, Estonia, Finland, Latvia, Lithuania, Poland, Sweden, DG Regio, European Commission

• Development of Research Infrastructures for the European Research Area

Prof. John Wood, Chairman of the ERA Board

• Stretegic aspects of research infrastructure development in Poland

Dr. Jacek Geirlinski, General Councel, Ministry of Science and Higher Education

• How can we develop effective technology transfer mechanisms in leading Polish bio tech-med research centres – the CePT approach

Dr. Marcin Szumowski, CePT Technology Transfer Platform coordinator

 

10.45 am - 11.15 pm

Coffee Break

 

11.15 pm - 13.45 pm

Session 1
International best practice in innovation management


In this session different models and leading examples of effective cooperation between science and industry with a focus on biotechnology and biomedicine will be presented based on the following proposed models:

• EMBL / EMBL Enterprise Management

Dr. Christian Boulin, EMBL Core Facilities director:
  EMBL Core facilities as a driver for Pan-European Research Infrastructures and Innovation
Dr. Antje Keppler, Euro-BioImaging Project Manager:
  Euro-BioImaging Project as a driver for innovation in biomedical imaging
Dr. Gábor M. Lamm, EMBLEM Technology Transfer GmbH Managing Director:
 Innovation Works™: A Pan-European Technology Transfer Model

• Weizmann Institute / Yeda Ltd.

Prof. Mordechai Sheves, Vice President for Technology Transfer:
  Excellence in research as a driver for effective technology transfer – the Weizmann Institute Model

• Danish Technical University / Symbion Innovation

Dr. Per Væggemose Nielsen, Senior Consultant, Group leader IPU Bio
   Multifaceted approach to effective university - industry collaboration

• Oxford University / ISIS Innovation Ltd.

Dr. Tim Cook, ISIS Innovation non-executive director:
  Establishing effective technology transfer at the University of Oxford

• European Investment Bank

Mr Thomas Barrett, director, European Investment Bank
 Funding proof-of-concept research via EIB risk-sharing mechanism for stimulating innovation
 

 

2.00 pm - 3.00 pm

 

3.00 pm - 4.00 pm

Ceremony of laying the foundation stone of Centre for Preclinical Research 

 

Buffet Lunch Break and Press Conference

 

4.00 pm - 6.00 pm

Session 2
  Biotech and Pharma industry perspective on cooperation with science,  technology transfer and translational research in the region

          Chairman and Moderator: Richard Hudson


   Technology Transfer through cooperation with research centres from the industry perspective – what biotech and pharmaceutical companies look for? Preferred forms of cooperation and absorption of scientific research results by the biotech and biomed industry sectors

 

  • 6 presentations by bio-tech and bio-med enterprises and VC funds (7 min each)

 

      o    Dr. Werner Kroll, Head of Innovation and Research Alliances, Novartis Molecular Diagnostics: Translational medicine: The Novartis approach to cooperation with academia
      o    Dr. Eric Lund, Associate Director, Asociated Director, Scientific Liaison, External Scientific Affairs, Merck & Co: Partnering with Today’s Merck
      o    Dr. Piotr Borowicz, Institute of Biotechnology and Antibiotics director, Bioton Board Member: Bioton an example of successful commercialization of Polish biotechnology
      o    Dr. Marek Dietl, Investment Manager, National Capital Fund (KFK SA): Smart Capital for Innovators
      o    Prof. Mirosław Miller, President of Wroclaw Research Centre EIT+ Ltd.: Financing models for IP commercialisation implemented by Wroclaw Research Centre EIT+
      o    Dr. Łukasz Kownacki, MD, ECZ Otwock: An example of innovative private clinic

 

  • Panel discussion on industry views on biotech sector and translational medicine development in the region

 

Panel: Werner Kroll, Eric Lund, Jan Lubinski, ReadGene SA, Pawel Mazurek, Medical University of Warsaw

 

 

7.00 pm

Conference Gala Dinner

Cafe Zamek of the Royal Castle in Warsaw

 

September 24

9.15 am - 10.15 am

Session 3
Management of intellectual property, research infrastructure and innovation

Session Chairman: Jacques Van der Meer, EIB -JASPERS Lead Expert, Knowledge Economy Team

Best practice approach to managing intellectual property through effective IP protection strategy, effective research infrastructure management and effective innovation management.

• Open Access to Research Infrastructure and Innovation

Prof. Keith G. Jeffery, Director, IT & International Strategy, STFC Rutherford Appleton Laboratory

• Open Innovation in practice: research, business and innovation campuses

Dr. Peter Tindemans, director Global Knowledge Strategies and Partnerships; former president OECD Megascience Forum

• Evolution of a Transatlantic Collaboration - The Mayo-ICRC Experience

Prof. Virend Somers, Professor of Medicine, Consultant in Cardiovascular Diseases, Director of Sleep and Cardiovascular Research Units of Mayo Center for Translational Science, and International Director, ICRC-Brno.

 

10.15 am - 10.45 am

Coffee Break


10.45 am - 12.30 pm

Session 4
Interactive Panel session focused on main challenges of managing RI and innovation at Central European R&D centres and clusters


Moderated by Richard Hudson
Panel: John Wood, Mark Mawhinney EIB-JASPERS, Jerzy Duszynski, Former Undersectetary of State at the MSHE, delegate to ESFRI

Discussion partners: R&D Centre managers from Poland and Czech Republic

 

Discussion engaging representatives and managers of large-scale IEOP Priority 2 RI projects in Poland and Czech Republic followed by the analysis of an interactive survey of main challenges and issues to be resolved in effective management of RI and R&D driven innovations

 

  • Effective management of RI as a way to assure sustainability and economic impact.

 

  • Developing effective Technology Transfer models based on clustering around large scale RI investments.

 

  • How to stimulate IP protection and Technology Transfer: Incentives and motivational systems for stimulating IP protection and Technology Transfer. 
 

12.30 pm - 12.45 pm

Coffee Break

 

12.45 pm - 13.30 pm

Summary Session – Concluding Remarks

Moderated by Richard Hudson
Panel: John Wood, Slawomir Majewski, Antonella Calvia, Marek Przeor, Marcin Szumowski


• Defining groups of key areas that require competence building and problem solving through targeted thematic workshops


• Defining the required / beneficial changes in the legal environment


• Proposing a preliminary schedule of workshops, hosted sequentially by each of the large-scale RI projects form IEOP Priority 2


• Closing remarks

 
 

2.00 pm - 6.00 pm

Optional satellite workshop
Dr. Robert Porter Lynch, CEO, The Warren Group
 Buidling systems of Trust for effective operational management and collaborative innovation.